BioLargo Free Cash Flow 2010-2025 | BLGO
BioLargo free cash flow from 2010 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| BioLargo Annual Free Cash Flow |
| 2024 |
-4.44 |
| 2023 |
-2.84 |
| 2022 |
-3.03 |
| 2021 |
-3.96 |
| 2020 |
-4.18 |
| 2019 |
-4.46 |
| 2018 |
-3.95 |
| 2017 |
-4.31 |
| 2016 |
-3.78 |
| 2015 |
-1.88 |
| 2014 |
-1.72 |
| 2013 |
-1.21 |
| 2012 |
-2.03 |
| 2011 |
-1.72 |
| 2010 |
-1.30 |
| 2009 |
-1.37 |
| BioLargo Quarterly Free Cash Flow |
| 2025-06-30 |
-3.95 |
| 2025-03-31 |
-1.83 |
| 2024-12-31 |
-4.44 |
| 2024-09-30 |
-2.55 |
| 2024-06-30 |
-0.89 |
| 2024-03-31 |
-0.38 |
| 2023-12-31 |
-2.84 |
| 2023-09-30 |
-2.70 |
| 2023-06-30 |
-1.65 |
| 2023-03-31 |
-0.09 |
| 2022-12-31 |
-3.03 |
| 2022-09-30 |
-2.97 |
| 2022-06-30 |
-1.97 |
| 2022-03-31 |
-1.17 |
| 2021-12-31 |
-3.96 |
| 2021-09-30 |
-2.98 |
| 2021-06-30 |
-2.08 |
| 2021-03-31 |
-0.86 |
| 2020-12-31 |
-4.18 |
| 2020-09-30 |
-3.31 |
| 2020-06-30 |
-2.03 |
| 2020-03-31 |
-0.74 |
| 2019-12-31 |
-4.46 |
| 2019-09-30 |
-3.21 |
| 2019-06-30 |
-1.87 |
| 2019-03-31 |
-0.87 |
| 2018-12-31 |
-3.95 |
| 2018-09-30 |
-3.09 |
| 2018-06-30 |
-2.08 |
| 2018-03-31 |
-1.02 |
| 2017-12-31 |
-4.31 |
| 2017-09-30 |
-3.08 |
| 2017-06-30 |
-2.05 |
| 2017-03-31 |
-1.18 |
| 2016-12-31 |
-3.78 |
| 2016-09-30 |
-2.85 |
| 2016-06-30 |
-1.70 |
| 2016-03-31 |
-0.99 |
| 2015-12-31 |
-1.88 |
| 2015-09-30 |
-1.34 |
| 2015-06-30 |
-0.81 |
| 2015-03-31 |
-0.28 |
| 2014-12-31 |
-1.72 |
| 2014-09-30 |
-1.42 |
| 2014-06-30 |
-1.01 |
| 2014-03-31 |
-0.56 |
| 2013-12-31 |
-1.21 |
| 2013-09-30 |
-0.99 |
| 2013-06-30 |
-0.83 |
| 2013-03-31 |
-0.47 |
| 2012-12-31 |
-2.03 |
| 2012-09-30 |
-1.66 |
| 2012-06-30 |
-1.12 |
| 2012-03-31 |
-0.38 |
| 2011-12-31 |
-1.72 |
| 2011-09-30 |
-1.34 |
| 2011-06-30 |
-1.01 |
| 2011-03-31 |
-0.42 |
| 2010-12-31 |
-1.30 |
| 2010-09-30 |
-0.71 |
| 2010-06-30 |
-0.58 |
| 2010-03-31 |
-0.24 |
| 2009-12-31 |
-1.37 |
| 2009-09-30 |
-0.89 |
| 2009-06-30 |
-0.70 |
| 2009-03-31 |
-0.27 |
| Sector |
Industry |
Market Cap |
Revenue |
| Construction |
Engineering - Research & Development Services |
$0.061B |
$0.018B |
|
BioLargo Inc. is a cleantech and life sciences innovator and engineering services solution provider. The company's core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs. BioLargo Inc. is based in WESTMINSTER, CA.
|
